Bio Protocol (BIO) is 114.7× the size of Cerebrum DAO (NEURON) by market capitalisation. Their daily returns move barely together (correlation 0.32 across 34 shared trading days). BIO has been the more volatile of the two, at 137% annualised against NEURON's 78%.
NEURONBIO
0.32over 34 shared trading days
Measured on daily returns rather than on prices. Two assets that both simply trend upward score near 1.0 on raw prices whether or not they move together, so returns are what answer the question people mean by correlation.
| Metric | NEURON | BIO |
|---|---|---|
| Max drawdown (400d) | -32.6% | -89.5% |
| Risk-adjusted return (90d) | -0.40 | -0.17 |
| Best 30 days (past year) | — | +253.8% |
| Worst 30 days (past year) | — | -52.7% |
Relative strength over 90 days: NEURON outperformed BIO by 1.3% — measured on the NEURON/BIO ratio, so it holds regardless of market direction.